CD209 and infection: The potency of inhibiting the DC-SIGN-mediated trans-infection with the authentic SARS-CoV-2 isolate by the glycomimetic compound PM26 was studied by six replicates using both systems, MDDC and Jurkat DC-SIGN (Fig 7A and 7B).